These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
253 related items for PubMed ID: 12664061
1. Specific block of androgen receptor activity by antisense oligonucleotides. Hamy F, Brondani V, Spoerri R, Rigo S, Stamm C, Klimkait T. Prostate Cancer Prostatic Dis; 2003; 6(1):27-33. PubMed ID: 12664061 [Abstract] [Full Text] [Related]
2. Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor. Culig Z, Hobisch A, Cronauer MV, Radmayr C, Trapman J, Hittmair A, Bartsch G, Klocker H. Cancer Res; 1994 Oct 15; 54(20):5474-8. PubMed ID: 7522959 [Abstract] [Full Text] [Related]
3. Androgen receptor down-regulation in prostate cancer with phosphorodiamidate morpholino antisense oligomers. Ko YJ, Devi GR, London CA, Kayas A, Reddy MT, Iversen PL, Bubley GJ, Balk SP. J Urol; 2004 Sep 15; 172(3):1140-4. PubMed ID: 15311058 [Abstract] [Full Text] [Related]
4. Inhibition of LncaP prostate cancer cells by means of androgen receptor antisense oligonucleotides. Eder IE, Culig Z, Ramoner R, Thurnher M, Putz T, Nessler-Menardi C, Tiefenthaler M, Bartsch G, Klocker H. Cancer Gene Ther; 2000 Jul 15; 7(7):997-1007. PubMed ID: 10917202 [Abstract] [Full Text] [Related]
5. Prosaposin upregulates AR and PSA expression and activity in prostate cancer cells (LNCaP). Koochekpour S, Lee TJ, Wang R, Culig Z, Delorme N, Caffey S, Marrero L, Aguirre J. Prostate; 2007 Feb 01; 67(2):178-89. PubMed ID: 17044040 [Abstract] [Full Text] [Related]
6. Inhibition of LNCaP prostate tumor growth in vivo by an antisense oligonucleotide directed against the human androgen receptor. Eder IE, Hoffmann J, Rogatsch H, Schäfer G, Zopf D, Bartsch G, Klocker H. Cancer Gene Ther; 2002 Feb 01; 9(2):117-25. PubMed ID: 11857028 [Abstract] [Full Text] [Related]
7. Androgen-dependent gene expression of prostate-specific antigen is enhanced synergistically by hypoxia in human prostate cancer cells. Horii K, Suzuki Y, Kondo Y, Akimoto M, Nishimura T, Yamabe Y, Sakaue M, Sano T, Kitagawa T, Himeno S, Imura N, Hara S. Mol Cancer Res; 2007 Apr 01; 5(4):383-91. PubMed ID: 17426252 [Abstract] [Full Text] [Related]
8. c-Jun enhancement of androgen receptor transactivation is associated with prostate cancer cell proliferation. Chen SY, Cai C, Fisher CJ, Zheng Z, Omwancha J, Hsieh CL, Shemshedini L. Oncogene; 2006 Nov 16; 25(54):7212-23. PubMed ID: 16732317 [Abstract] [Full Text] [Related]
9. Androgen receptor protein is down-regulated by basic fibroblast growth factor in prostate cancer cells. Cronauer MV, Nessler-Menardi C, Klocker H, Maly K, Hobisch A, Bartsch G, Culig Z. Br J Cancer; 2000 Jan 16; 82(1):39-45. PubMed ID: 10638964 [Abstract] [Full Text] [Related]
10. Involvement of transcription factor Sp1 in quercetin-mediated inhibitory effect on the androgen receptor in human prostate cancer cells. Yuan H, Gong A, Young CY. Carcinogenesis; 2005 Apr 16; 26(4):793-801. PubMed ID: 15661808 [Abstract] [Full Text] [Related]
11. Activation of p300 histone acetyltransferase activity and acetylation of the androgen receptor by bombesin in prostate cancer cells. Gong J, Zhu J, Goodman OB, Pestell RG, Schlegel PN, Nanus DM, Shen R. Oncogene; 2006 Mar 30; 25(14):2011-21. PubMed ID: 16434977 [Abstract] [Full Text] [Related]
12. Androgen receptor level controlled by a suppressor complex lost in an androgen-independent prostate cancer cell line. Wang LG, Ossowski L, Ferrari AC. Oncogene; 2004 Jul 01; 23(30):5175-84. PubMed ID: 15156193 [Abstract] [Full Text] [Related]
13. Novel steroid receptor phyto-modulator compound a inhibits growth and survival of prostate cancer cells. Yemelyanov A, Czwornog J, Gera L, Joshi S, Chatterton RT, Budunova I. Cancer Res; 2008 Jun 15; 68(12):4763-73. PubMed ID: 18559523 [Abstract] [Full Text] [Related]
14. Gene expression changes following androgen receptor elimination in LNCaP prostate cancer cells. Eder IE, Haag P, Basik M, Mousses S, Bektic J, Bartsch G, Klocker H. Mol Carcinog; 2003 Aug 15; 37(4):181-91. PubMed ID: 12891627 [Abstract] [Full Text] [Related]
15. Sterol regulatory element-binding protein-1c represses the transactivation of androgen receptor and androgen-dependent growth of prostatic cells. Suh JH, Gong EY, Kim JB, Lee IK, Choi HS, Lee K. Mol Cancer Res; 2008 Feb 15; 6(2):314-24. PubMed ID: 18245227 [Abstract] [Full Text] [Related]
16. TR2 orphan receptor functions as negative modulator for androgen receptor in prostate cancer cells PC-3. Mu X, Chang C. Prostate; 2003 Oct 01; 57(2):129-33. PubMed ID: 12949936 [Abstract] [Full Text] [Related]
17. GCP-mediated growth inhibition and apoptosis of prostate cancer cells via androgen receptor-dependent and -independent mechanisms. Tepper CG, Vinall RL, Wee CB, Xue L, Shi XB, Burich R, Mack PC, de Vere White RW. Prostate; 2007 Apr 01; 67(5):521-35. PubMed ID: 17252539 [Abstract] [Full Text] [Related]
18. Comparative effects of DHEA vs. testosterone, dihydrotestosterone, and estradiol on proliferation and gene expression in human LNCaP prostate cancer cells. Arnold JT, Le H, McFann KK, Blackman MR. Am J Physiol Endocrinol Metab; 2005 Mar 01; 288(3):E573-84. PubMed ID: 15536203 [Abstract] [Full Text] [Related]
19. Exisulind and related compounds inhibit expression and function of the androgen receptor in human prostate cancer cells. Lim JT, Piazza GA, Pamukcu R, Thompson WJ, Weinstein IB. Clin Cancer Res; 2003 Oct 15; 9(13):4972-82. PubMed ID: 14581372 [Abstract] [Full Text] [Related]
20. Decoy androgen-responsive element DNA can inhibit androgen receptor transactivation of the PSA promoter gene. Zhang P, Zhang J, Young CY, Kao PC, Chen W, Jiang A, Zhang L, Guo Q. Ann Clin Lab Sci; 2005 Oct 15; 35(3):278-84. PubMed ID: 16081584 [Abstract] [Full Text] [Related] Page: [Next] [New Search]